• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CARGO Therapeutics downgraded by Chardan Capital Markets

    1/30/25 7:52:27 AM ET
    $CRGX
    Get the next $CRGX alert in real time by email
    Chardan Capital Markets downgraded CARGO Therapeutics from Buy to Neutral
    Get the next $CRGX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CRGX

    DatePrice TargetRatingAnalyst
    1/30/2025Buy → Neutral
    Chardan Capital Markets
    1/30/2025$32.00 → $3.00Buy → Hold
    Jefferies
    1/30/2025$34.00 → $4.00Overweight → Neutral
    Piper Sandler
    1/30/2025Outperform → Mkt Perform
    William Blair
    1/30/2025Overweight → Underweight
    Analyst
    1/30/2025$32.00 → $7.00Buy → Hold
    Truist
    1/30/2025Buy → Neutral
    H.C. Wainwright
    11/26/2024Outperform
    William Blair
    More analyst ratings

    $CRGX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Samsara Biocapital Gp, Llc bought $4,998,000 worth of shares (294,000 units at $17.00) (SEC Form 4)

      4 - CARGO Therapeutics, Inc. (0001966494) (Issuer)

      6/3/24 9:45:28 PM ET
      $CRGX